IL6 and susceptibility to pneumonia measurement: Among patients with pneumonia, use of ticagrelor reduced platelet-leukocyte interaction, lowered interleukin-6 level, and improved lung function32, serving as potential physiological mechanisms how it prevents pneumonia-specific death.